Haemorrhagic cystitis (HC) is a common complication after haematopoietic stem cell transplantation (HSCT) referring to bleeding from the bladder mucosa due to urinary bladder inflammation. Early-onset HC has been associated with bladder mucosal damage by chemotherapy or radiotherapy in the conditioning phase, while late-onset HC in the peri-engraftment period is increasingly associated with BK polyoma virus infection.
Even though there have been significant developments in transplant practices over the last years, HC in transplant patients has not been investigated among EBMT centres in the last decade. Therefore, the current study aims to obtain information on both the practices and management, as well as the incidence and outcome, of HC in EBMT transplant patients.
This centre-level survey focuses on the first part: Practices and management of HC post-allogeneic HSCT among EBMT centres
